On October 18, 2021, RedShift BioAnalytics, Inc. closed the transaction. The transaction was led by new investor, IIF Management Company, LLC. The transaction also includes participation from returning investors, Technology Venture Partners, LLC and Waters Corporation and other investors.

The company raised $9,999,998 pursuant to Regulation D from 12 investors.